Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03110744
Title CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma (NCT-PMO-1601)
Acronym NCT-PMO-1601
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University Hospital Heidelberg
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Additional content available in CKB BOOST